Genetic variability in E6, E7 and L1 genes of Human Papillomavirus 62 and its prevalence in Mexico

Infectious Agents and Cancer

Volumn 12, Issue 1, 2017, Pages

  Artaza Irigaray, Cristina ^a,b   Flores Miramontes, María Guadalupe ^a,b   Olszewski, Dominik ^c   Magaña Torres, María Teresa ^a   López Cardona, María Guadalupe ^d   Leal Herrera, Yelda Aurora ^e   Piña Sánchez, Patricia ^a   Jave Suárez, Luis Felipe ^a   Aguilar Lemarroy, Adriana ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Hospital Regional Dr Valentin Gomez Farias   (Mexico)

^e DEPARTAMENTO DE FÍSICA APLICADA   (Mexico)

Author keywords

Cervical cancer; E6; E7; HPV62; L1

Indexed keywords

CAPSID PROTEIN L1; PROTEIN E6; PROTEIN E7;

ANIMAL TISSUE; ARTICLE; CANCER GRADING; CONTROLLED STUDY; E6 GENE; E7 GENE; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 62; L1 GENE; MEXICO; NEXT GENERATION SEQUENCING; NONHUMAN; PREVALENCE; PROTEIN STRUCTURE; SANGER SEQUENCING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENOME; WART VIRUS;

EID: 85014460044     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/s13027-017-0125-x     Document Type: Article

References (38)

1. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed 6 June 2016.
2. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-50.
3. Pedraza-Brindis EJ, Sanchez-Reyes K, Hernandez-Flores G, Bravo-Cuellar A, Jave-Suarez LF, Aguilar-Lemarroy A, Gomez-Lomeli P, Lopez-Lopez BA, Ortiz-Lazareno PC. Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages. Cell Immunol. 2016;310:42-52.
4. Ma Y, Madupu R, Karaoz U, Nossa CW, Yang L, Yooseph S, Yachimski PS, Brodie EL, Nelson KE, Pei Z. Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. J Virol. 2014;88(9):4786-97.
5. Bravo IG, Félez-Sánchez M. Papillomaviruses viral evolution, cancer and evolutionary medicine. Evol med public health. 2015;2015(1):32-51.
6. Comprehensive Cervical Cancer Prevention and Control. WHO. 2013.
7. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin H-R. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56.
8. Munoz N, Castellsagué X, de González AB, Gissmann L. HPV in the etiology of human cancer. Vaccine. 2006;24:S1-S10.
9. De Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27.
10. Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445(1):232-43.
11. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550-60.
12. Klingelhutz AJ, Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high-and low-risk viruses. Virology. 2012;424(2):77-98.
13. Fu L, Terai M, Matsukura T, Herrero R, Burk RD. Codetection of a mixed population of candHPV62 containing wild-type and disrupted E1 open-reading frame in a 45-year-old woman with normal cytology. J Infect Dis. 2004;190(7):1303-9.
14. Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortes-Gutierrez EI, Salgado-Bernabe ME, Ramos-Gonzalez NP, Ortega-Cervantes L, Arias-Flores R, Medina-Diaz IM, Hernandez-Garza F, Santos-Lopez G, et al. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015;87(5):871-84.
15. Siqueira JD, Alves BM, Prellwitz IM, Furtado C, Meyrelles AR, Machado ES, Seuanez HN, Soares MA, Soares EA. Identification of novel human papillomavirus lineages and sublineages in HIV/HPV-coinfected pregnant women by next-generation sequencing. Virology. 2016;493:202-8.
16. Flores-Miramontes MG, Torres-Reyes LA, Alvarado-Ruíz L, Romero-Martínez SA, Ramírez-Rodríguez V, Balderas-Peña LM, Vallejo-Ruíz V, Piña-Sánchez P, Cortés-Gutiérrez EI, Jave-Suárez LF. Human papillomavirus genotyping by linear array and next-generation sequencing in cervical samples from Western Mexico. Virol J. 2015;12(1):161.
17. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol. 1999;80(Pt 9):2437-43.
18. Li J, Pan Y, Xu Z, Wang Q, Hang D, Shen N, Liu M, Zhang C, Abliz A, Deng Q, et al. Improved detection of human papillomavirus harbored in healthy skin with FAP6085/64 primers. J Virol Methods. 2013;193(2):633-8.
19. Papillomavirus Episteme (PaVE). https://pave.niaid.nih.gov. Accessed 12 July 2016.
20. Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5(4):725-38.
21. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER suite: protein structure and function prediction. Nat Methods. 2015;12(1):7-8.
22. I-Tasser Protein Structure and Function Predictions. zhanglab.ccmb.med.umich.edu/I-TASSER/. Accessed 20 July 2016.
23. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008;9(1):40.
24. Bernard H-U, Chan S-Y, Manos MM, Ong C-K, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 1994;170(5):1077-85.
25. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM. Prevalence of alphapapillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol. 2006;78(12):1663-72.
26. Datta P, Bhatla N, Dar L, Patro AR, Gulati A, Kriplani A, Singh N. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol. 2010;34(2):157-61.
27. Shaltout MF, Sallam HN, AbouSeeda M, Moiety F, Hemeda H, Ibrahim A, Sherbini ME, Rady H, Gopala K, DeAntonio R. Prevalence and type distribution of human papillomavirus among women older than 18 years in Egypt: a multicenter, observational study. Int J Infect Dis. 2014;29:226-31.
28. Youssef MA, Abdelsalam L, Harfoush RA, Talaat IM, Elkattan E, Mohey A, Abdella RM, Farhan MS, Foad HA, Elsayed AM. Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test. Infect agents cancer. 2016;11(1):1.
29. Kantathavorn N, Mahidol C, Sritana N, Sricharunrat T, Phoolcharoen N, Auewarakul C, Teerayathanakul N, Taepisitpong C, Saeloo S, Sornsamdang G. Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs. Infect agents cancer. 2015;10(1):7.
30. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, Markowitz LE. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006. J Infect Dis. 2011;204(4):566-73.
31. Roksandić-Križan I, Bošnjak Z, Perić M, Crossed D signurkin I, Zujić Atalić V, Vuković D. Distribution of Genital Human Papillomavirus (HPV) Genotypes in Croatian Women with Cervical Intraepithelial Neoplasia (CIN)-A Pilot Study. Coll Antropol. 2013;37(4):1179-83.
32. Santos FM, Gurgel A, Lobo C, Freitas A, Silva-Neto J, Silva L. Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women. Genetics and molecular research. GMR. 2016;15(2):1-9.
33. So KA, Kim MJ, Lee K-H, Lee I-H, Kim MK, Lee YK, Hwang C-S, Jeong MS, Kee M-K, Kang C. The impact of high-risk HPV genotypes other than HPV 16/18 on the natural course of abnormal cervical cytology: a Korean HPV cohort study. Cancer Res Treat. 2016;48(4):1313.
34. Gurgel APAD, Chagas BS, Amaral CMM, Albuquerque EMB, Serra IGSS, Silva Neto JC, Muniz MTC, Freitas AC. Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil. Biomed Res Int. 2013;2013:546354.
35. Thomas M, Narayan N, Pim D, Tomaić V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L. Human papillomaviruses, cervical cancer and cell polarity. Oncogene. 2008;27(55):7018-30.
36. Rastogi RP, Kumar A, Tyagi MB, Sinha RP. Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids. 2010;2010:592980.
37. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10(3):512-26.
38. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33(7):1870-4.